Peter Scott Chin
Chief Medical Officer · Denali Therapeutics Inc.
- 2026
- Sep 9, 2026
- 1
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Peter Scott Chin files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Nancy Thornberry - $262K in DNLI purchases and sales in the last 12 months
- Alexander O. Schuth - $137K in DNLI purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Peter Scott Chin?
Peter Scott Chin is a corporate insider, tracked as Chief Medical Officer of Denali Therapeutics Inc. (DNLI). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Peter Scott Chin submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Peter Scott Chin been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($37K) across all tracked filings.
